Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Hyperfine (HYPR) EBT (2021 - 2025)

Hyperfine (HYPR) has disclosed EBT for 5 consecutive years, with -$11.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 6.71% year-over-year to -$11.0 million, compared with a TTM value of -$40.1 million through Sep 2025, up 2.35%, and an annual FY2024 reading of -$40.7 million, up 7.95% over the prior year.
  • EBT was -$11.0 million for Q3 2025 at Hyperfine, down from -$9.2 million in the prior quarter.
  • Across five years, EBT topped out at -$7.8 million in Q1 2021 and bottomed at -$26.1 million in Q4 2021.
  • Average EBT over 5 years is -$13.3 million, with a median of -$10.8 million recorded in 2023.
  • The sharpest move saw EBT plummeted 205.04% in 2022, then soared 54.07% in 2023.
  • Year by year, EBT stood at -$26.1 million in 2021, then skyrocketed by 49.94% to -$13.1 million in 2022, then rose by 18.19% to -$10.7 million in 2023, then increased by 2.75% to -$10.4 million in 2024, then fell by 6.05% to -$11.0 million in 2025.
  • Business Quant data shows EBT for HYPR at -$11.0 million in Q3 2025, -$9.2 million in Q2 2025, and -$9.4 million in Q1 2025.